Cancer BiologybioRxivPreprint
Canonical microRNA loss drives tumor development implicating therapeutic efficacy of enoxacin in angiosarcoma
Ant Murphy, Bozhi Liu, Annaleigh Benton…·Jason A. Hanna
The paper shows that loss of miRNA processing drives angiosarcoma and that enoxacin enhances miRNA expression, reducing tumor cell viability and migration.
DOI 10.1101/2025.07.15.664801